Our first finding was that the IUGR samples showed the greatest transcript variation, displaying down-regulation of genes involved in neuroactive ligand-receptor interaction, fatty acid biosynthesis, and pathways involving NOS3 activity, including arginine biosynthesis and metabolism, angiogenesis as well as the VEGF signaling pathway. The gene discussed is VEGFA; the disease is fetal growth restriction.